Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabbit ATG-Fresenius With Cyclosporin in Acquired Aplastic Anaemia
NCT02028416Unknown
- Sponsor
- National Institute of Blood Diseases and Bone Marrow Transplantation
- Start
- Sep 2013
- Primary completion
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Randomised trial of antithymocyte globulin rabbit in aplastic anemia (2 arms), sponsored by National Institute of Blood Diseases and Bone Marrow Transplantation. Primary endpoint: Absolute blood counts not meeting the criteria of Aplastic Anemia at 6 months. Status: unknown.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT02028416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02028416.